Related references
Note: Only part of the references are listed.A Distinct Subset of Atypical Spitz Tumors is Characterized by BRAF Mutation and Loss of BAP1 Expression
Thomas Wiesner et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma
Yoshie Yoshikawa et al.
CANCER SCIENCE (2012)
Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma Families
Ching-Ni Jenny Njauw et al.
PLOS ONE (2012)
Melanocytic Nevi With An Atypical Epithelioid Cell Component: Clinical, Histopathologic, and Fluorescence In Situ Hybridization Findings
Pedram Pouryazdanparast et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers
Mohamed H. Abdel-Rahman et al.
JOURNAL OF MEDICAL GENETICS (2011)
Germline mutations in BAP1 predispose to melanocytic tumors
Thomas Wiesner et al.
NATURE GENETICS (2011)
Germline BAP1 mutations predispose to malignant mesothelioma
Joseph R. Testa et al.
NATURE GENETICS (2011)
Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
J. William Harbour et al.
SCIENCE (2010)
Fluorescence In Situ Hybridization (FISH) as an Ancillary Diagnostic Tool in the Diagnosis of Melanoma
Pedram Gerami et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
BRCA1-Associated Protein 1 Interferes with BRCA1/BARD1 RING Heterodimer Activity
Hiroyuki Nishikawa et al.
CANCER RESEARCH (2009)
The Deubiquitinating Enzyme BAP1 Regulates Cell Growth via Interaction with HCF-1
Yuichi J. Machida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization
Karen H. Ventii et al.
CANCER RESEARCH (2008)
Proteolytic processing is necessary to separate and ensure proper cell growth and cytokinesis functions of HCF-1
E Julien et al.
EMBO JOURNAL (2003)
Share Paper
